Estrogens and Estramustine Phosphate

[1]  R. Sylvester,et al.  A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer. , 1986, The Journal of urology.

[2]  R. Benson,et al.  Estramustine Phosphate Compared with Diethylstilbestrol A Randomized, Double‐Blind, Crossover Trial for Stage D Prostate Cancer , 1986, American journal of clinical oncology.

[3]  R. Priore,et al.  Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer. , 1986, Urology.

[4]  P. Gunnarsson,et al.  Clinical pharmacokinetics of estramustine phosphate. , 1984, Urology.

[5]  P. Gunnarsson,et al.  Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145). , 1982, The Journal of urology.

[6]  P. Walsh,et al.  Hormonal Therapy of Prostatic Cancer , 1980, Cancer.

[7]  G. Murphy,et al.  Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma. , 1977, Urology.

[8]  E. Lindstedt,et al.  The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer. , 1976, Investigative urology.

[9]  Høisaeter Pa.  Incorporation of 3H-thymidine into rat ventral prostate in organ culture. Influence of hormone-cytostatic complexes. , 1975 .

[10]  G. Murphy,et al.  Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol. , 1974, Cancer research.

[11]  D. Byar.  The veterans administration cooperative urological research group's studies of cancer of the prostate , 1973, Cancer.

[12]  C. Huggins,et al.  Studies on Prostatic Cancer. III. The Effects of Fever, of Desoxycorticosterone and of Estrogen on Clinical Patients with Metastatic Carcinoma of the Prostate1,2 , 1941 .

[13]  L. Daehlin.  On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma. , 1985, Scandinavian journal of urology and nephrology. Supplementum.

[14]  B. Hartley‐åsp.  Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3 , 1984 .

[15]  R. Nagel,et al.  Estracyt therapy of advanced prostatic cancer with special reference to control of therapy with cytology and DNA cytophotometry. , 1980, European urology.

[16]  P. Esposti,et al.  Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study. , 1980, Scandinavian journal of urology and nephrology. Supplementum.

[17]  H. Gustafson,et al.  Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients. , 1980, Scandinavian journal of urology and nephrology. Supplementum.

[18]  G. Murphy,et al.  5α-Reductase as a Target Enzyme for Anti-Prostatic Drugs in Organ Culture , 1977 .

[19]  E. Diczfalusy,et al.  Treatment of prostatic carcinoma with various types of estrogen derivatives. , 1975, Vitamins and hormones.

[20]  K. Griffiths,et al.  The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissue. , 1970, Steroids.